Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown
South African Family Practice
| Field | Value | |
| Title | Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown | |
| Creator | Siemens, Jo-Marie A. Bhoora, Urvisha Janse van Rensburg, Michelle | |
| Description | Background: Temporary shelters were established for street-based people during the national level 5 coronavirus disease 2019 (COVID-19) lockdown. However, street-based substance users’ need to access substances was not addressed, resulting in large numbers of people experiencing withdrawal. The Community Oriented Substance Use Programme (COSUP) in Tshwane provided methadone to manage opioid withdrawal.Methods: A cross-sectional, descriptive study was conducted using the daily methadone dosing records from shelters in Tshwane between March 2020 and September 2020.Results: The final analysis included 495 participants, of which 64 (12.9%) were initiated on 20 mg – 30 mg of methadone, 397 (80.2%) on 40 mg – 50 mg, and 34 (6.9%) on 60 mg – 70 mg. A total of 194 (39.2%) participants continued their initiation dose for 1–2 months, after which 126 (64.9%) had their doses increased, and 68 (35.1%) had their doses decreased. Approximately 12 (2.4%) participants were weaned off methadone after 1–3 months and 46 (9.3%) after 4–6 months. In all, 100 (20.2%) participants left the shelter prematurely and did not continue with methadone. A total of 126 (25.5%) participants continued to stay in the shelters and received methadone for 6 months, with 125 (25.3%) participants leaving the shelter with continued follow-up at a COSUP site.Conclusion: This study demonstrates variability in methadone dosing regimens among shelter residents. As the lockdown measures eased, many chose to leave the shelters, while others remained to receive methadone and other services. The COSUP appears to be effective during periods of increased vulnerability, since a large number of participants were successfully followed up.Contribution: Opioid dependence is a persistent, lifelong disease. It is multifaceted with complex environmental and individual determinants. This study highlighted the use of opioid substitution therapy during a period of increased vulnerability. | |
| Publisher | AOSIS | |
| Date | 2023-09-05 | |
| Identifier | 10.4102/safp.v65i1.5708 | |
| Source | South African Family Practice; Vol 65, No 1 (2023): Part 4; 7 pages 2078-6204 2078-6190 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://safpj.co.za/index.php/safpj/article/view/5708/8201
https://safpj.co.za/index.php/safpj/article/view/5708/8202
https://safpj.co.za/index.php/safpj/article/view/5708/8203
https://safpj.co.za/index.php/safpj/article/view/5708/8204
|
|
ADVERTISEMENT
